These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730 [TBL] [Abstract][Full Text] [Related]
23. Ischemic acute renal failure in the rat: effects of L-arginine and superoxide dismutase on renal function. Schramm L; Seibold A; Schneider R; Zimmermann J; Netzer KO; Wanner C J Nephrol; 2008; 21(2):229-35. PubMed ID: 18446718 [TBL] [Abstract][Full Text] [Related]
24. [Glomerular hemodynamics in the isolated and perfused kidney. Effect of the inhibition of nitric oxide synthase]. Gabbai FB; Peterson OW; Khang S Gac Med Mex; 1997; 133(4):307-13. PubMed ID: 9410792 [TBL] [Abstract][Full Text] [Related]
25. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651 [TBL] [Abstract][Full Text] [Related]
26. Assessment of endothelial function of the renal vasculature in human subjects. Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856 [TBL] [Abstract][Full Text] [Related]
27. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
28. Impaired renal haemodynamic response to L-arginine in essential hypertension: role of buffering anion and tubuloglomerular feedback. Biggi A; Carra N; Cabassi A; Barilli AL; Musiari L; Iori M; De Iaco G; Azzarone M; Novarini A; Montanari A J Hypertens; 2007 Mar; 25(3):679-88. PubMed ID: 17278985 [TBL] [Abstract][Full Text] [Related]
29. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study. Bech JN; Aagaard NK; Pedersen RS; Sorensen TB; Vilstrup H; Pedersen EB Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512 [TBL] [Abstract][Full Text] [Related]
30. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo. Yada T; Shimokawa H; Hiramatsu O; Shinozaki Y; Mori H; Goto M; Ogasawara Y; Kajiya F J Am Coll Cardiol; 2007 Sep; 50(13):1272-8. PubMed ID: 17888845 [TBL] [Abstract][Full Text] [Related]
32. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes. Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619 [TBL] [Abstract][Full Text] [Related]
33. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics. Epstein M; Hollenberg NK Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985 [No Abstract] [Full Text] [Related]
35. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study. Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772 [TBL] [Abstract][Full Text] [Related]
36. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329 [TBL] [Abstract][Full Text] [Related]
37. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats. Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342 [TBL] [Abstract][Full Text] [Related]
38. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy. Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097 [TBL] [Abstract][Full Text] [Related]
39. Basal cerebral blood flow is dependent on the nitric oxide pathway in elderly but not in young healthy men. Kamper AM; Spilt A; de Craen AJ; van Buchem MA; Westendorp RG; Blauw GJ Exp Gerontol; 2004 Aug; 39(8):1245-8. PubMed ID: 15288698 [TBL] [Abstract][Full Text] [Related]
40. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]